South Koreas Deputy PM Warns AI Wealth Concentration Risks Worsening Inequality Amid Samsung Labor Strife
PDD Holdings Stock Declines as Temu Parents Quarterly Revenue Falls Short of Market Expectations
JK Cements 13 Volume Growth Outpaces Industry Amid Cost Pressures
CBS and Paramount Retreat from Copyright Enforcement Following Stephen Colberts Viral Parody
SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags
Geopolitical Risk Irans Suspicion of US Ceasefire Terms Adds Uncertainty for Energy Markets
LEXX Q1 2026 Earnings Loss Narrower Than Expected Stock Jumps 73
Vaxcyte Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Investment Phase
VLYPN Q1 2026 Earnings Preferred Stock EPS Beats Estimates by 507
CRGO Q1 2026 Earnings EPS Misses Estimates by Nearly 70 No Revenue Reported Stock Slides 574
Ready Capital Q1 2026 Earnings Massive EPS Miss Highlights Credit Deterioration
Harrow Inc Q1 2026 Earnings Pharmaceutical Firm Misses EPS Estimates by Wide Margin
Regional Management Corp RM Edges Higher as Support Holds Steady
Bankwell Financial Group BWFG Inches Higher Regional Bank Showcases Measured Recovery
Santacruz Silver Mining SCZM Declines 193 as Shares Test Support Near 750
Sweetgreen Inc SG Posts Strong Gains Stock Jumps 89 as Bulls Test Resistance Near 1027
Meta Platforms Edges Higher Amid Consolidation Key Levels in Focus
Indias Renewable Energy Sector Faces Grid Integration Headwinds in Q1 2026 Despite 275 GW Capacity Milestone
UHAL Q1 2026 Earnings Significant EPS Miss Despite Modest Stock Gain
Haymaker Acquisition Corp 4 HYAC Edges Higher as SPAC Holds Above Trust Value
Total Return Securities Fund SWZ Holds Steady at 596 Key Levels in Focus
NeuroSense Therapeutics NRSN Edges Higher Testing Resistance at 095
Oklo Inc OKLO Surges 338 as Stock Approaches Key Resistance Level
EnerSys ENS Declines 25 as Shares Test Key Support Zone
Davis Commodities Limited DTCK Holds Steady at 100 Consolidation Phase for Commodity Player
Cadrenal Therapeutics CVKD Holds Steady Above Support as Traders Eye Resistance at 545
FibroBiologics FBLG Holds Steady at 105 as Biotech Sector Awaits Catalyst